LEWIS, RUSSELL EDWARD

LEWIS, RUSSELL EDWARD  

Dipartimento di Medicina Molecolare - DMM  

Mostra records
Risultati 1 - 20 di 49 (tempo di esecuzione: 0.046 secondi).
Titolo Data di pubblicazione Autori Rivista Serie Titolo libro
A Prospective Multicentre Study of the Epidemiology and Outcomes of Bloodstream Infection in Cirrhotic Patients 2018 Lewis, RussellCaraceni, PaoloBURRA, PATRIZIA + CLINICAL MICROBIOLOGY AND INFECTION - -
Antifungal prophylaxis in adult patients with acute myeloid leukaemia treated with novel targeted therapies: a systematic review and expert consensus recommendation from the European Hematology Association 2022 Lewis R. + THE LANCET. HAEMATOLOGY - -
Antifungal Prophylaxis in the Era of Targeted Chemotherapy for Acute Myelogenous Leukemia 2023 Lewis, Russell E. + CURRENT FUNGAL INFECTION REPORTS - -
Breakthrough invasive fungal infection after liver transplantation in patients on targeted antifungal prophylaxis: A prospective multicentre study 2021 Ferrarese A.Cillo U.Burra P.Lewis R. + TRANSPLANT INFECTIOUS DISEASE - -
Breakthrough mucormycosis developing on mucorales-active antifungals portrays a poor prognosis in patients with hematologic cancer 2021 Jiang Y.Lewis R. E. + JOURNAL OF FUNGI - -
Carbapenem-resistant bacteria in an intensive care unit during the coronavirus disease 2019 (COVID-19) pandemic: A multicenter before-and-after cross-sectional study 2022 Lewis R. + INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY - -
Ceftolozane-tazobactam treatment of hypervirulent multidrug resistant pseudomonas aeruginosa infections in neutropenic patients 2020 Lewis R. E. + MICROORGANISMS - -
Chimeric antigen receptor T-cell immunotherapy and need for prophylaxis for invasive mold infections 2020 Lewis R. E. + CLINICAL INFECTIOUS DISEASES - -
Chimeric antigen receptor T-cell therapy for the treatment of lymphoid malignancies: is there an excess risk for infection? 2021 Lewis R. E. + THE LANCET. HAEMATOLOGY - -
Clinical consequences of very major errors with semi-automated testing systems for antimicrobial susceptibility of carbapenem-resistant Enterobacterales 2022 Bassetti M.Marchese A.Lewis R. + CLINICAL MICROBIOLOGY AND INFECTION - -
Combination antifungal therapy for breakthrough invasive mould disease in patients with haematological malignancies: When management reasoning eclipses evidence-based medicine 2020 Lewis R. E. + JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY - -
Core recommendations for antifungal stewardship: a statement of the mycoses study group education and research consortium 2020 Lewis R. E. + THE JOURNAL OF INFECTIOUS DISEASES - -
Critically ill patients with COVID-19 show lung fungal dysbiosis with reduced microbial diversity in patients colonized with Candida spp 2022 Lewis R. + INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES - -
Development and internal validation of a model for predicting 60-day risk of invasive mould disease in patients with haematological malignancies 2019 Lewis R. E. + JOURNAL OF INFECTION - -
Development of a Risk Prediction Model for Carbapenem-Resistant Enterobacteriaceae Infection after Liver Transplantation: A Multinational Cohort Study 2021 Ferrarese, AlbertoBurra, PatriziaLewis, Russell + CLINICAL INFECTIOUS DISEASES - -
Early low-dose computed tomography with pulmonary angiography to improve the early diagnosis of invasive mould disease in patients with haematological malignancies: A pilot study 2021 Lewis R. + JOURNAL OF INFECTION - -
Epidemiology of Invasive Pulmonary Aspergillosis among Intubated Patients with COVID-19: A Prospective Study 2021 Fornaro G.Rubin A.Trapani F.Lewis R. + CLINICAL INFECTIOUS DISEASES - -
Extended infusion of β-lactams for bloodstream infection in patients with liver cirrhosis: an observational multicenter study 2019 Lewis, Russell ECaraceni, PaoloBurra, Patrizia + CLINICAL INFECTIOUS DISEASES - -
Follow-up blood cultures are associated with improved outcome of patients with gram-negative bloodstream infections: retrospective observational cohort study 2020 Lewis R. + CLINICAL MICROBIOLOGY AND INFECTION - -
How long do we need to treat an invasive mold disease in hematology patients? factors influencing duration of therapy and future questions 2020 Lewis R. E. + CLINICAL INFECTIOUS DISEASES - -